When compared to conventionally fractionated radiotherapy, toxicity was shown to be less prevalent in the SBRT arm of the SPACE trial, including rates of esophagitis (8% vs 30%), borderline significant pneumonitis (19% vs 34%) and dyspnea (67% vs 81%)[ 14 ].
← all excerpts
Stereotactic body radiation therapy for non-small cell lung cancer: A review.
1
—
—